Engaging students in wellness and disease prevention services

American Journal of Pharmaceutical Education

Volumn 70, Issue 2, 2006, Pages

  Anderson, Audra S ^a,b   Goode, Jean Venable R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Ukrop's Pharmacy   (United States)

Author keywords

Advanced pharmacy practice experiences; Community pharmacy; Disease prevention; Health promotion; Wellness

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CURRICULUM; EDUCATION; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; PHARMACY STUDENT; PRIMARY PREVENTION;

ATTITUDE TO HEALTH; CURRICULUM; EDUCATION, PHARMACY; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; PRIMARY PREVENTION; STUDENTS, PHARMACY;

EID: 33646470588     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj700240     Document Type: Article

References (41)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
2. U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. 2 vols. Washington, DC: U.S. Government Printing Office;2000. Available at: www.healthypeople.gov. Accessed January 18, 2006.
3. Babb VJ, Babb J. Pharmacist involvement in Healthy People 2010. J Am Pharm Assoc. 2003;43:56-60.
4. Calis KA, Hutchinson LC, Elliott ME, Ives TJ, et al. Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy. 2004;24:1241-94.
5. Educational Outcomes 2004. Center for Advancement of Pharmaceutical Education. American Association of Colleges of Pharmacy. 2004. Available at www.aacp.org/Docs/MainNavigation/Resources/6075_CAPE2004.pdf. Accessed February 17, 2005.
6. 2005 National Health Observances. National Health Information Center, Office of Disease Prevention and Health Promotion, US Department of Health and Human Services, Washington, DC. Available at: www.healthfinder.gov/library/nho/ nho.asp. Accessed July 11, 2005.
7. Ciardulli LM, Goode JR. Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc. 2003;43:61-8.
8. Dombrowski SR. Pharmacist counseling on nutrition and physical activity - part 1 of 2: understanding current guidelines. J Am Pharm Assoc. 1999;39:479-91.
9. Dombrowski SR, Ferro LA. Pharmacist counseling on nutrition and physical activity - part 2 of 2: helping patients make changes. J Am Pharm Assoc. 1999;39:613-27.
10. Giles JT, Kennedy DT, Dunn EC, et al. Results of a community pharmacy-based breast cancer risk assessment and education program. Pharmacotherapy. 2001;21:243-53.
11. Boyle TC, Coffey J, Palmer T. Men's health initiative risk assessment study: effect of community pharmacy-based screening. J Am Pharm Assoc. 2004;44:569-77.
12. DeHart RM, Gonzalez EH. Osteoporosis: Point-of-Care Testing. Ann Pharmacother. 2004;38:473-81.
13. Rosenthal WM. Implementing bone mineral density testing in the community pharmacy. J Am Pharm Assoc. 2000;40:737-45.
14. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT Osteoporosis. J Am Pharm Assoc. 2004;152-60.
15. Elliot ME, Meek PD, Kanous NL, et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc. 2002;42:101-10.
16. Tice B, Phillips CR. Implementation and evaluation of a lipid screening program in a large chain pharmacy. J Am Pharm Assoc. 2002;42:413-9.
17. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
18. Carter BL. Pharmaceutical Care for Hypertensive patients. Am Pharm. 1994;NS34:54-61.
19. Park JJ, Kelly P, Carter BL, Buirgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996;36:443-51.
20. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-85.
21. Magnum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50-5.
22. Zerumsky K, Steinmetz KL, Handler SM, et al. Pharmacist detection of peripheral arterial disease through the use of a handheld Doppler. Pharmacotherapy. 2005;25:797-802.
23. Rosenthal WM. Establishing a pharmacy-based laboratory service. J Am Pharm Assoc. 2000;40:146-56.
24. States where pharmacists can provide immunizations. American Pharmacists Association. Available at: www.aphanet.org/pharmcare/ImmunizationInformation. htm#States%20where. Accessed July 15, 2005.
25. Guidelines for pharmacy-based immunization advocacy. American Pharmacists Association. Available at: www.aphanet.org/pharmcare/immguide.html. Accessed July 15, 2005.
26. Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. JAMA. 2002;287:3245-8.
27. Guide to Clinical Preventative Services 2005. United States Preventative Health Services Task Force. Available at: www.ahrq.gov/clinic/pocketgd.htm. Accessed July 15, 2005.
28. Mullen PD, Hershey JC, Iverson DC. Health behavior models compared. Soc Sci Med. 1987;24:973-81.
29. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall; 1980
30. Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am J Health-Syst Pharm. 1995;52:282-7.
31. Lange N, Tigges BB. Influence positive change with motivational interviewing. Nurse Pract. 2005;30:44-53.
32. Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in a community pharmacy practice. J Am Pharm Assoc. 2002;42:83-92.
33. Kennedy DT, Giles JT, Ghnag ZG, et al. Results of a smoking cessation clinic in a community pharmacy practice. J Am Pharm Assoc. 2002;42:51-6.
34. A Clinical Practice Guideline for Treating Tobacco Use and Dependence. US Public Health Service Report. JAMA. 2000;283:3244-54.
35. Rigotti NA. Treatment of Tobacco Use and Dependence. N Engl J Med. 2002;346:506-12.
36. Haggerty SA, Cerulli J, Zeolla MM, Cottrell JS, Weck MB, Faragon JJ. A Community pharmacy Target Intervention Program (TIP) to improve aspirin use in persons with diabetes. J Am Pharm Assoc. 2005;45:17-22.
37. Mc Donough RP, Doucette WR. Using personal selling skills to promote pharmacy services. J Am Pharm Assoc. 2003;43:363-72.
38. Holdford DA. Using buzz marketing to promote ideas, services, and products. J Am Pharm Assoc. 2004;44:387-96.
39. Holdford DA. Marketing for Pharmacists. Washington, DC: American Pharmacists Association; 2003.
40. Kucukarslan S, Schommer JC. Patients' expectations and their satisfaction with pharmacy services. J Am Pharm Assoc. 2002;42:489-95.
41. Larson LN, Rovers JP, Mackeigan LD. Patient satisfaction with pharmaceutical care: update of a validated instrument. J Am Pharm Assoc. 2002;42:44-50.